Haemonetics
HAE
#2913
Rank
C$8.01 B
Marketcap
C$176.05
Share price
1.60%
Change (1 day)
69.20%
Change (1 year)

EPS for Haemonetics (HAE)

EPS in 2026 (TTM): C$3.20

According to Haemonetics's latest financial reports the company's current EPS (TTM) is C$3.26. In 2025 the company made an earnings per share (EPS) of C$5.24 an increase over its 2024 EPS that were of C$3.67.

EPS history for Haemonetics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$3.20-39.01%
2025C$5.2442.68%
2024C$3.672.43%
2023C$3.5933.73%
2022C$2.68332.49%
2021C$0.62
2018C$1.28-363.15%
2017C-$0.49-207.1%
2016C$0.45-132.28%
2015C-$1.41-269%
2014C$0.83-20%
2013C$1.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.57 193.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
C$5.85 79.41%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
C$27.21 735.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C-$2.02-162.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
C$5.16 58.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
C$13.54 315.54%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
C$11.03 238.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Cerus Corporation
CERS
C-$0.04299-101.32%๐Ÿ‡บ๐Ÿ‡ธ USA